healthcare AI
Blood Tests Plus CT or AI Improve Lung Cancer Identification
Catharina/TU/e: blood markers plus CT or AI identified ~73–78% of lung-cancer cases in 346 patients; AI comparable to radiologists. Research poster stage.
Latest
AI Reasoning Models Diagnose Better but Add 34% More False Positives
AI reasoning models made more accurate diagnoses but over 34% more false positives in a retrospective study; doctors checking them cut those by 44%.
NCS Plans to Triple Its Embedded AI Engineers to 300 in Singapore
NCS has opened an AI Mission Centre in Singapore and plans to grow its client-embedded AI engineers from 100 to over 300 within two years.
Singapore AI Model Explains Its Reading of Medical Scans, Paper Says
A*STAR and Duke-NUS researchers built EVLF-FM, an AI model that diagnoses across 10 scan types and points to evidence. It is not ready for clinical use.
AI Tool Picks Out Aggressive Prostate Cancer in a 63-Biopsy Test
NEURAL-PC, built by Fred Hutch, NCI and partners, scores routine biopsy slides for neuroendocrine prostate cancer. It is a research tool, not a diagnostic.
UCLA’s MAESTRO AI Ranked 3,592 Compounds to Pair With a Cancer Drug
UCLA's MAESTRO uses large language models to rank drug pairs. It flagged berberine with enzalutamide, which worked together in lab prostate cancer models.
Meta Gives Five US Universities $2m and Its AI Models for Research
Meta is granting $2m across Caltech, Ohio State, LSU, Indiana and UTHealth Houston for research using its AI models, from infant care to heart failure.
UCL Digital Twins Suggest Extra Drugs for Hard-to-Treat Breast Cancer
UCL's symbolic AI built digital twins of 31 breast tumours, matched 74% of trial outcomes and proposed extra drugs. None has been tested in patients.
Anthropic Reports Claude Drug Work at Six Partners and Buys Mithril
Anthropic says Claude cut document review time by 89% at Enveda and helped design antibodies and CAR T parts. It has also bought Mithril Medicine.
FDA Clears MRI-Based AI That Scores 10-Year Breast Cancer Return Risk
TumorSight Risk turns a pre-surgery breast MRI and five clinical facts into 5- and 10-year recurrence estimates. What FDA cleared, and what the data show.
ESMO Study: Routine Health Data Flags Higher Risk of 20 Cancers
Models built on blood tests and medical history flagged higher risk of 20 common cancers in an ESMO 2026 study, but many flags will be false.
Related stories
Latest from topics connected to healthcare AI. See all with connected topics
Latest on TSN
Explore the TSN Atlas: Every topic we cover, mapped. Click a bubble to dive in.